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ABSTRACT
Background: Delays resulting from the transfer to perform 
primary percutaneous coronary intervention (PCI) have a 
negative impact on the benefits of the procedure. Methods: 
Prospective registry aimed at comparing the results of primary 
PCI in patients with ST-segment elevation myocardial infarc-
tion (STEMI) admitted or transferred to an interventional cath 
lab equipped hospital. Results: Between February 2009 and 
December 2011, 319 patients were included in the study 
with mean age of 59.8 ± 12 years, 28.5% were female and 
22.3% were diabetics. Patients transferred for primary PCI 
(n = 201) had longer door-to-balloon time (86.4 ± 26.6 min 
vs 69 ± 22.6 min; P < 0.0001), a non-significant decrease in 
ST-segment elevation resolution (83.5% vs 90.4%; P = 0.18), 
final TIMI 3 flow (90.1% vs 94.1%; P = 0.30), myocardial 
blush grade 3 (74.3% vs 78.8%; P = 0.22) and angiographic 
success (90.1% vs 94.1%; P = 0.30), and a non-significant 
increase in major bleeding (2% vs 0.9%; P = 0.20) and 
hospital mortality (6.5% vs 4%; P = 0.29). Conclusions: The 
referral of patients with STEMI directly to an interventional 
cath lab equiped hospital is associated with shorter door-to-
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RESUMO
Impacto da Transferência Inter-hospitalar  
nos Resultados da Intervenção Coronária  
Percutânea Primária
Introdução: Atrasos decorrentes da transferência para reali zação 
de intervenção coronária percutânea (ICP) primária impactam 
negativamente os benefícios do procedimento. Métodos: Re-
gistro prospectivo objetivando comparar os re sultados da ICP 
primária entre pacientes com infarto agudo do miocárdio com 
supradesnivelamento do segmento ST (IAMCSST) admitidos ou 
transferidos para hospital equipado com laboratório de inter-
venção. Resultados: Entre fevereiro de 2009 e dezembro de 
2011, foram incluídos 319 pacientes, com média de idade de 
59,8 ± 12 anos, 28,5% do sexo feminino e 22,3% diabéticos. 
Pacientes transferidos para realização de ICP primária (n = 201) 
apresentaram tempo porta -balão mais longo (86,4 ± 26,6 min 
vs. 69 ± 22,6 min; P < 0,0001), diminuição não significativa 
da resolução do supradesnivelamento do segmento ST (83,5% 
vs. 90,4%; P = 0,18), do fluxo final TIMI 3 (90,1% vs. 94,1%; 
P = 0,30), do blush miocárdico grau 3 (74,3% vs. 78,8%; P = 0,22) 
e do sucesso angiográfico (90,1% vs. 94,1%; P = 0,30), e in-
cremento não significativa de sangramento grave (2% vs. 0,9%; 
P = 0,20) e mortalidade hospitalar (6,5% vs. 4%; P = 0,29). 
Conclusões: O encaminhamento do paciente com IAMCSST 
diretamente a hospital com laboratório de intervenção asso cia -se 
a menor tempo porta balão e melhora não significativa dos 
marcadores de reperfusão e da mortalidade.
 
DESCRITORES: Infarto do miocárdio. Angioplastia. Transferência 
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P rimary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for acute myocardial infarction with ST segment elevation myocardial 
infarction (STEMI), provided that it is performed within 
the first 90 minutes after the diagnosis by experienced 
staff at a high-volume center.1 Until 2006, statistics 
from the United States showed that approximately 25% 
of hospitals had no access to primary PCI and that 
only 10% of patients were treated within the optimal 
time range suggested by the guidelines.2 Updated data 
have reported an improved mean door-to-balloon time 
of 64.5 minutes, increasing to 121 minutes in trans-
ferred patients.3 In Brazil, preliminary results from the 
Clinical Practice Registry for Acute Coronary Syndrome 
(ACCEPT), which represents 47 national referral institu-
tions, have observed a mean 125-minute delay between 
the diagnosis and the completion of the procedure; 
only 36% of cases were effectively treated in less than 
90 minutes.4 
Strategies aimed at reducing the delay when perfor-
ming primary PCI are a topic of current and increasing 
interest. A meta-regression analysis of 5,741 patients in 
11 randomized trials demonstrated the superiority of 
transferring patients to undergo primary PCI compared 
with performing local fibrinolysis in reducing morta-
lity, recurrent myocardial infarction (MI) and stroke.5 
However, these findings are applicable to the patients 
included in these studies, which were characterized by 
reduced door-to-balloon times, and thus not applicable 
to the real world, in which delays arising from patient 
transfers are commonly observed. In this scenario, the 
benefits determined by mechanical reperfusion can be 
attenuated or lost completely.
This study aimed to evaluate the impact of inter-
hospital transfer on the efficacy and safety outcomes in 
patients with STEMI undergoing primary PCI in the city 
of Marília, SP, Brazil, which offers an integrated and 
efficient care system for cardiovascular emergencies.
METHODS
The present study analyzed a prospective registry 
of consecutive patients diagnosed with STEMI who 
underwent primary PCI (within 12 hours of evolution) 
in Marília, SP, Brazil. With an estimated population of 
226,000 inhabitants (based on the most recent census 
of the Brazilian Institute of Geography and Statistics 
[Instituto Brasileiro de Geografia e Estatística – IBGE]), 
the city has 12 basic health units (BHU) and two 
emergency hospitals (EH) that belong to the Brazilian 
Unified Health System (Sistema Único de Saúde – SUS) 
network. Two tertiary hospitals, one of which is equipped 
with an interventional cardiology lab that operates 24 
hours a day, seven days a week, with an annual volume 
of over 500 annual PCI procedures, constituted the 
reference point for treating cardiovascular emergen-
cies. Transportation between the basic units and the 
tertiary hospitals, as well as inter-hospital transportation 
(distance of approximately 2 km), are performed by 
the Emergency Mobile Care Service (Serviço de Aten-
dimento Móvel de Urgência – SAMU). Patients with a 
pre-hospital diagnosis of STEMI are taken directly to the 
interventional laboratory, after telephone contact with 
the staff in charge, thus preventing delays arising from 
the necessity to go through the emergency department. 
Patients who were transferred for primary percuta-
neous coronary intervention were compared to those 
who were admitted directly to a hospital capable of 
performing the procedure. The evaluated efficacy out-
comes included the angiographic success rate, restora-
tion of epicardial Thrombolysis in Myocardial Infarction 
(TIMI) 3 flow, myocardial blush grade 3, resolution of 
ST-segment elevation > 50%, and in-hospital morta-
lity. The safety outcome consisted of severe bleeding. 
In accordance with the classification of the Bleeding 
Academic Research Consortium,6 severe bleeding was 
defined according to the following categories: type 3 
([3a] bleeding with a decrease in haemoglobin ≥ 3 and 
<  5 g/dL or a transfusion of packed red blood cells; 
[3b] bleeding with a decrease in haemoglobin ≥  5 g/
dL, cardiac tamponade, bleeding requiring surgical 
intervention, or bleeding requiring intravenous vasoac-
tive drugs; [3c] intracranial haemorrhage, as confirmed 
by autopsy or subcategories, imaging examinations or 
lumbar puncture, or intraocular bleeding with vision 
impairment); or type 5 ([5a] probable fatal bleeding, 
[5b] definite fatal bleeding). Transportation time was 
defined as the interval between the electrocardiogram 
(EKG) diagnosis and the patient’s arrival at the interven-
tional laboratory. Symptom-to-balloon time was defined 
as the interval between symptom onset and the cross-
ing of the lesion with pre-dilatation balloon, manual 
aspiration catheter, or stent. Door-to-balloon time was 
defined as the interval between the EKG diagnosis and 
crossing the lesion with pre-dilatation balloon, manual 
aspiration catheter, or stent.
The statistical analysis was performed with SPSS 
software, release 12.0 (SPSS Inc. – Chicago, USA). 
Cate gorical variables were expressed as absolute num-
bers and their percentages and were compared with 
the chi-squared test or Fisher’s exact test. Continuous 
variables were expressed as means and standard 
deviations and were compared using Student’s t-test. 
Statistically significant results were determined with 
a P-value <  0.05. 
RESULTS
Between February 2009 and December 2011, 319 
patients who were diagnosed with STEMI and underwent 
primary PCI were included in the study, 118 of whom 
were directly admitted to a tertiary hospital equipped 
with an interventional cardiology laboratory; 201 pa-
tients were initially treated at tertiary hospitals lacking 
these facilities, and were later transferred to another 
hospital to undergo the procedure.
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The clinical and demographic characteristics of the 
sample are shown in Table 1. The subjects’ mean age 
was 59.8 ± 12 years; 71.5% were males, and 22.3% 
had diabetes mellitus. The characteristics of the proce-
dures were similar between groups, except for higher 
transportation time (52.5 ± 23.4 minutes vs. 14.1 ± 
11.4 minutes; P < 0.0001), longer symptom-to-balloon 
time (5 ± 2.2 hours vs. 3.3 ± 2.2 hours; P < 0.0001), 
and higher door-to-balloon time (86.4 ± 26.6 minutes 
vs. 69 ± 22.6 minutes; P < 0.0001) in the transferred 
patients (Table 2).
The predominant arterial access route was the trans-
radial approach (96.6%), whereas the femoral approach 
was used in nine cases (2.8%), and the ulnar approach 
in two cases (0.6%). The failure rate of the transradial 
approach was 0.97% (three cases), due to chronic 
occlusion of the innominate artery, severe tortuosity 
of the radial artery, and lack of support for the PCI 
performance. In 99% of the procedures, 6F introducers 
were used; stents were implanted in 95.9% of cases.
The patients who were transferred for primary 
PCI had lower rates of resolution of ST-segment eleva-
tion, final TIMI 3 flow, myocardial blush grade 3, and 
angiographic success, with a non-significant increase 
of severe bleeding and in-hospital mortality (Table 3).
The main determinants of inter-hospital transfer 
delay include the delays related to patient referral (e.g., 
authorization by the Hospital Bed Regulatory System and 
SAMU availability) in 190 cases (94.5%), factors related 
to the intervention center (e.g., availability of a multi-
disciplinary team and simultaneous use of the unit for 
another procedure) in nine cases (4.5%), and delays in 
inter-hospital transportation in two cases (1%) (Figure 1).
DISCUSSION
The study results demonstrate that the organiza-
tion and use of an integrated care system for patients 
with STEMI, even among those patients transferred for 
primary percutaneous coronary intervention, achieve a 
door-to-balloon time within the range recommended by 
the guidelines. However, the present findings should 
be interpreted with caution. The choice of strategy for 
inter-hospital transfers necessarily promotes an increase 
in transportation time, symptom-to-balloon time, and 
door-to-balloon time, to the detriment of local fibrino-
lysis.7 In Marília, the inter-hospital distance is only 2 
km, and the city does not have the difficulties that are 
inherent to the urban traffic of metropolitan regions. 
In addition, although not statistically significant, the 
transferred patients had lower resolution rates of S-T 
segment elevation, final TIMI 3 flow, myocardial blush 
grade 3, and angiographic success, with increased rates 
of severe bleeding and in-hospital mortality.
In fact, data from the National Registry of Myocardial 
Infarction (NRMI) show that the benefit of transfers for 
primary PCI compared to fibrinolysis is time-dependent. 
Mortality rates alone, mortality/reinfarction rates, and 
mortality/reinfarction/stroke rates are lower and more 
favourable compared to primary PCI when the delay to 
the start of treatment is less than 60 minutes or 60-90 
minutes; the benefit becomes questionable when this time 
exceeds 90 minutes and is absent after 120 minutes.8 
Thus, it becomes imperative to develop strategies that 
facilitate access to primary PCI and reduce the door-
to-balloon time. The most common attributable causes 
of delay for inter-hospital transfer are those related to 
referral (e.g., waiting for transportation; unclear or non-
diagnostic EKG), followed by delays in the intervention 
Table 1  







n = 118 P
Mean age, years 59.8 ± 1.2 58.2 ± 11.6 62.6 ± 12.3 0.001
Females, n (%) 91 (28.5) 61 (30.3) 30 (25.4) 0.37
Diabetes mellitus, n (%) 71 (22.3) 36 (17.9) 35 (29.7) 0.017
Arterial hypertension, n (%) 210 (65.8) 130 (64.7) 81 (68.6) 0.54
Dyslipidemia, n (%) 93 (29.2) 47 (23.4) 46 (38.9) 0.004
Current smoking, n (%) 147 (46.1) 106 (52.7) 41 (34.7) 0.002
Family history of heart failure, n (%) 49 (15.4) 26 (12.9) 23 (19.5) 0.15
Previous acute myocardial infarction, n (%) 19 (5.9) 11 (5.5) 8 (6.8) 0.63
Previous CABG surgery, n (%) 6 (1.9) 3 (1.5) 3 (2,5) 0.67
Previous PCI, n (%) 19 (15.4) 8 (4) 11 (9.3) 0.08
CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention.
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n = 118 P
Call between 7AM and 7PM, n (%) 192 (60,2) 123 (61.2) 68 (57.6) 0.56
Call between 7 PM and 7 AM, n (%) 127 (39.8) 78 (38.8) 50 (42.4) 0.56
Weekends, n (%) 101 (31.7) 66 (32.8) 35 (30) 0.62
Transportation time, minutes 38.1 ± 27.1 52.5 ± 23.4 14.1 ± 11.4 < 0.0001
Symptom-to-balloon time, hours 4.3 ± 2.3 5 ± 2.2 3.3 ± 2.2 < 0.0001
Door-to-balloon time, minutes 79.9 ± 26.5 86.4 ± 26.6 69 ± 22.6 < 0.0001
Single-vessel coronary disease, n (%) 158 (49.5) 103 (51.2) 55 (46.6) 0.49
Anterior descending culprit artery, n (%) 147 (46.1) 98 (48.8) 50 (42.4) 0.30
Killip III-IV, n (%) 32 (10.1) 19 (9.7) 12 (10.7) 0.83
Transradial access, n (%) 308 (96.6) 196 (97.5) 112 (94.9) 0.34
Duration of procedure, minutes 45.1 ± 20.5 43.7 ± 17.9 47.6 ± 24.2 0.10
Fluoroscopy time, minutes 11.3 ± 7.4 10.8 ± 6.7 11.9 ± 8.5 0.20
Type B2/C lesion, n (%) 290 (90.9) 183 (91) 107 (90.7) > 0.99
Aspiration catheter, n (%) 174 (54.5) 108 (53.7) 66 (55,9) 0.73
IIb/IIIa glycoprotein inhibitor, n (%) 230 (72.1) 143 (71.1) 87 (73.7) 0.70
0-1 pre TIMI flow, n (%) 273 (85.6) 174 (86.6) 99 (83.8) 0.51
Pre-dilation, n (%) 179 (56.1) 118 (58.7) 61 (51.7) 0.24
Stent implantation, n (%) 306 (95.9) 195 (97) 111 (94.1) 0.24
Intra-aortic balloon, n (%) 5 (1.6) 1 (0.5) 4 (3.4) 0.064
Table 3 







n = 118 P
Resolution of ST-segment elevation  
> 50%, n (%)
207 (86.6) 121 (83.5) 106 (90.4) 0.18
Final TIMI 3 flow, n (%) 292 (91.5) 181 (90.1) 111 (94.1) 0.30
Myocardial blush grade 3, n (%) 232 (74.8) 149 (74.3) 93 (78.8) 0.22
Angiographic success, n (%) 292 (91.5) 181 (90.1) 111 (94.1) 0.30
Severe bleeding, n (%) 6 (1.9) 4 (2) 2 (0.9) 0.20
In-hospital mortality, n (%) 18 (5.6) 13 (6.5) 5 (4) 0.29
center (e.g., staff availability and procedure complexity) 
and the transportation of patients (e.g., distances, weather 
and geographical features).9 In the present study, the 
major factors were waiting for the transportation and 
bureaucratic transfer regulations.
The direct transportation of patients with a pre-
hospital diagnosis of STEMI to the interventional car-
diology lab, preceded by contact and team awareness, 
is a simple measure that is capable of increasing by 
three-fold the proportion of patients treated within 
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the recommended therapeutic window, which results 
in higher rates of final TIMI 3 flow; this outcome, in 
turn, is an important predictor of long-term survival.10 
Moreover, the use and activation of emergency medi-
cal services, consisting of professionals trained in the 
interpretation of 12-lead EKG and the possibility of 
transmitting the electrocardiographic tracing elsewhere 
(telemetry), culminating with direct patient transporta-
tion to the interventional laboratory, have been shown 
to significantly reduce reperfusion times and mortality 
rates at six months for these patients.11,12
The role of the pharmaco-invasive strategy in this 
context is still debatable. Although the immediate 
performance of PCI after fibrinolysis as a facilitating 
tool has promoted increased mortality when com-
pared with primary PCI alone,13 more recent studies 
have demonstrated favorable outcomes for the routine 
transfer of patients undergoing fibrinolysis followed by 
invasive stratification within the first six to 24 hours 
after lytic administration.14-17 Despite the natural inte-
rest in establishing a single protocol for the care of 
patients with STEMI, including a universal and standard 
reperfusion therapy, the high variability in the results 
comparing transfer for primary PCI and fibrinolysis is 
influenced by the delay to the start of treatment, the 
patient’s risk profile, and the experience of the local 
staff; the hospital structure predicts the adoption of an 
individualized analysis and the decision-making process 
based on these factors.
Study Limitations
The limitations of this study include the fact that 
it was observational and nonrandomized, the limited 
number of patients (which hinders the inference of effi-
cacy and safety outcomes), the inability to determine 
the actual interval between the patient’s admission 
time and the procedure start time (which is why the 
door-to-balloon time was chosen), and the absence of 
clinical information after the hospital discharge, given 
the high rate of morbidity and cumulative mortality in 
this clinical setting.
CONCLUSIONS
In spite of an integrated emergency system, which 
allows for an inter-hospital transfer time interval < 60 
minutes, referring a patient diagnosed with STEMI 
directly to a hospital equipped with an interventional 
laboratory is associated with decreased total ischemia 
time, reduced door-to-balloon time, improved myocardial 
reperfusion markers, and a non-significant decrease in 
hospital mortality.
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